Trial Profile
An Open-Label, Multi-Center, International Study to Investigate Drug-Drug Interactions Between AT2220 and Alglucosidase Alfa in Patients With Pompe Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Duvoglustat (Primary) ; Alglucosidase alfa
- Indications Glycogen storage disease type II
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Amicus Therapeutics
- 19 May 2014 New trial record